J B Chemicals & Pharmaceuticals has allotted 11,582 equity shares under ESOS on 04 June 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,52,01,476 equity shares of Re. 1 each to 15,52,13,058 equity shares of Re. 1 each. Powered by Capital Market - Live News

The Board of J B Chemicals & Pharmaceuticals at its meeting held on 03 June 2024 has recommended the appointment of Arun Duggal (DIN: 00024262) as director in the category of Non-Executive and Independent Director. Powered by Capital Market - Live News

Net profit of J B Chemicals & Pharmaceuticals rose 43.97% to Rs 126.16 crore in the quarter ended March 2024 as against Rs 87.63 crore during the previous quarter ended March 2023. Sales rose 13.04% to Rs 861.73 crore in the quarter ended March 2024 as against Rs 762.32 crore during the previous quarter ended March 2023.For the full year,net profit rose 34.84% to Rs 552.63 crore in the year ended March 2024 as against Rs 409.83 crore during the previous year ended March 2023. Sales rose 10.63% to Rs 3484.18 crore in the year ended March 2024 as against Rs 3149.28 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales861.73762.32 13 3484.183149.28 11 OPM %22.9921.47 -25.7422.09 - PBDT205.34154.26 33 889.83669.64 33 PBT164.60122.46 34 751.51555.23 35 NP126.1687.63 44 552.63409.83 35 Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 17 May 2024, inter alia, have recommended the final dividend of Rs 6.75 per equity Share (i.e. 675%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 17 May 2024Powered by Capital Market - Live News